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Abstract. Addition of bombesin to quiescent cultures 
of Swiss 3T3 cells caused a rapid increase in the phos- 
phorylation of an Mr 80,000 cellular protein (desig- 
nated 80k). The effect was both concentration and 
time dependent; enhancement in 80k phosphorylation 
could be detected as early as 10 s after the addition of 
peptide. Recently, a rapid increase in the phosphoryla- 
tion of an 80k cellular protein after treatment with 
phorbol esters or diacylglycerol has been shown to 
reflect the activation of protein kinase C in intact 
fibroblasts (Rozengurt, E., A. Rodriguez-Pena, and K. 
A. Smith,  1983, Proc. Natl. Acad. Sci.  USA., 80:7244- 
7248; Rozengurt, E., A. Rodriguez-Pena, M. Coombs, 
and J. Sinnett-Smith,  1984, Proc. Natl. Acad. Sci. 
USA., 81:5748-5752). The 80k phosphoproteins gen- 
erated in response to bombesin and to phorbol  12,13- 
dibutyrate were identical as judged by one- and two- 
dimensional PAGE and by peptide mapping after 
partial proteolysis with Staphylococcus aureus V8 pro- 
tease. In addition, prolonged pretreatment of 3T3 cells 
with phorbol  12,13-dibutyrate, which leads to the dis- 
appearance of protein kinase C activity, blocked the 
ability of bombesin to stimulate 80k. Bombesin also 
caused a rapid (1 min) inhibition of 125I-labeled epi- 
dermal growth factor (125I-EGF) binding to Swiss 3T3 
cells.  The inhibition was both concentration and tem- 
perature dependent and resulted from a marked de- 
crease in the affinity of the EGF receptor for its li- 
gand. Peptides structurally related to bombesin, in- 
cluding gastrin-releasing peptide, also stimulated 80k 
phosphorylation and inhibited 125I-EGF binding; both 
effects were selectively blocked by a novel bombesin 
antagonist. These results strongly suggest that these 
responses are mediated by specific high-affinity recep- 
tors that recognize the peptides of the bombesin fam- 
ily in Swiss 3T3 cells.  While an increase in cytosolic 
Ca  2+ concentration does not mediate the bombesin 
inhibition of ~25I-EGF binding, the activation of pro- 
tein kinase C in intact Swiss 3T3 cells by peptides of 
the bombesin family may lead to rapid inhibition of 
the binding of ~25I-EGF to its cellular receptor. 
arge  number  of new  regulatory  peptides  have  been 
identified in the brain, gastrointestinal tract, and other 
tissues (13,  23,  45). These  peptides,  which  elicit a 
multiplicity of biological responses, appear to behave as local 
hormones or neurotransmitters  acting in a paracrine  or au- 
tocrine fashion on adjacent cells. Bombesin, a tetradecapep- 
tide originally isolated from amphibian skin (1), has potent 
pharmacological  effects  in  animals  (22,  47,  67,  68),  and 
peptides structurally  related  to bombesin,  including gastrin- 
releasing  peptide  (GRP)  ~ and  the  neuromedins  have  been 
identified in a number of mammalian tissues (21, 36, 38-40, 
1.  Abbreviations  used  in  this paper:  DME,  Dulbeceo's modified Eagle's 
medium; EGF,  epidermal growth factor;, FDGF,  fibroblast-derived  growth 
factor;  GRP, gastrin-releasing  peptide; OAG,  l-oleoyl-2-acetylglycerol;  PBtz, 
phorbol 12,13-dibutyrate; PDGF, platelet-derived growth factor, SP, substance 
P. 
70, 71). Recently, several reports have also demonstrated  the 
presence of high levels of bombesin-like peptides in human 
pulmonary (19, 41, 52, 72) and thyroid (35) carcinomas. 
Bombesin  is a  potent mitogen  for Swiss 3T3  cells (56). 
Strikingly,  in  contrast  to  other  growth-promoting  agents, 
bombesin  shares  with  both  platelet-derived  growth  factor 
(PDGF) (51) and  the PDGF-like  fibroblast-derived  growth 
factor (FDGF) (18, 58) the ability to stimulate DNA synthesis 
and cell division in the absence of other mitogens. Recently, 
we demonstrated  that mammalian  analogues ofbombesin are 
also mitogenic for Swiss 3T3 cells. The mitogenic response to 
these peptides is mediated by specific, high-affinity receptors 
that are distinguishable from those of other growth factors for 
these cells, including PDGF (73). Furthermore,  both receptor 
binding  and mitogenesis are selectively blocked by a novel 
bombesin antagonist  (27, 73). Thus,  this family of peptides 
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current hypotheses regarding the control of cellular prolifer- 
ation (53, 55). 
In this and the following paper (37), we have examined the 
effect of bombesin and structurally related peptides on some 
of the initial cellular responses that are being implicated in 
the control of a proliferative response (53). These studies on 
the mechanism of bombesin-induced mitogenesis assume an 
added  significance  in  view  of recent  findings  implicating 
bombesin in a self-stimulatory (autocrine) growth circuit that 
contributes to the unrestrained growth of small cell carcinoma 
of the lung (14, 65). 
Ca2+-sensitive,  phospholipid-dependent  protein  kinase 
(protein kinase C) which is stimulated by diacylglycerol and 
by tumor promoters of the phorbol ester family (42),  may 
play a fundamental role in the stimulation of fibroblast pro- 
liferation (for review see reference 60).  It was, therefore, of 
importance to determine whether bombesin and related pep- 
tides activate protein kinase C  in intact cells.  Recently, we 
found that a rapid increase in the phosphorylation of an Mr 
80,000 cellular protein (designated 80k) reflects the activation 
of protein kinase C in intact cells (60, 61). The salient features 
of the evidence supporting this conclusion are as follows. (a) 
Biologically  active  phorbol  esters  or  diacylglycerols either 
exogenously added (59) or endogenously generated (61) stim- 
ulate a rapid phosphorylation of this protein. (b) Prolonged 
pretreatment of 3T3 cells with phorbol ester, which leads to 
a marked decrease in the number of specific phorbol ester- 
binding sites (8-10,  54) and to the disapperance of protein 
kinase C activity in vitro (48, 60) blocks the increase in 80k 
phosphorylation elicited by phorbol esters or diacylglycerol. 
(c) The same 80k phosphorylation can be generated in cell- 
free extracts by activation of  protein kinase C (i.e., by addition 
of phosphatidylserine,  Ca  :+,  and  phorbol  12,13-dibutyrate 
[PBtz] in the presence of [3,-32p]ATP) (50). The nature of 80k 
remains to be established, but the detection of changes in its 
phosphorylation provides a  novel approach with which  to 
assess the mitogenic agents that activate protein kinase C in 
intact cells. 
Recent findings obtained with intact cells (15, 26, 64) and 
cell-free  systems (7,  25)  suggest  that  activation  of protein 
kinase C  may play a central role in the modulation of the 
affinity of epidermal growth factor (EGF) receptors for its 
ligand  by a set of structurally unrelated mitogens (3, 5,  11, 
30, 34, 57, 58, 62-64). It has also been reported that bombesin 
reduces the association of ~:5I-EGF to 3T3 cells (4) and to 
pancreatic acinar cells, an effect apparently mediated by an 
increase in the cytosolic Ca  2+ concentration (28,  31, 46).  In 
the course of our studies concerning the early events elicited 
by peptides of the bombesin family in quiescent Swiss 3T3 
cells, we examined the effect of these peptides on the binding 
and internalization of ~25I-EGF into Swiss 3T3 cells, and the 
parts played by protein kinase C and an increase in cytosolic 
Ca  2+  in  mediating  the  inhibition  of  t2SI-EGF association 
caused by bombesin. 
On the basis of the results presented here, we conclude that 
the activation of protein kinase C is one of the earliest events 
that follows the interaction of  peptides of  the bombesin family 
with  specific,  high-affinity receptors.  Our  findings  further 
show that activation of protein kinase C  leads to the rapid 
decrease in ~2SI-EGF  binding caused by these peptides. 
Materials and Methods 
Cell Culture 
Swiss 3T3 cells (69) were maintained  as previously described and subeultured 
to 33-ram Nunc dishes (105 cells/dish) in Dulbecco's modified Eagle's medium 
(DME) containing  10%  fetal bovine  serum.  After  5-7  d, the cultures  were 
confluent  and quiescent as shown by autoradiography  (<1%  labeled nuclei) 
after a 40-h exposure to [~H]thymidine (16). 
Labeling of Cells with 32pi 
The cultures were washed twice with DME without phosphate and incubated 
with this medium containing  200 or 400 uCi/ml of carrier-free azp~ for both 
one- and two-dimensional PAGE at 37"C for 4 h to label the endogenous ATP 
pool. Bombesin, PBh, or other agents were then added for various times. The 
reaction was stopped by removing the medium and rapidly washing the cultures 
twice with ice-cold Tris-saline  solution (0.15 M NaCI, 20 mM Tris-HCl, pH 
7.5). The cells were immediately extracted with 5% trichloroacetic acid at 4"C 
for 20 rain. The acid-soluble pools were removed; the precipitated protein was 
washed twice with Tris-saline and dissolved with 100 ~l of  a solution containing 
3% SDS, 5% glycerol, 10 mM Tris-HC1, pH 7.8, 2% 2-mercaptoethanol,  and 
1 mM phenylmethylsulfonyl fluoride heated at 100*C. After 2 rain, the samples 
were placed  in  a  boiling  water  bath  for  10  min  before  resolution  by  gel 
electrophoresis. 
SDS PAGE 
Slab gel electrophoresis was performed using a 5-15% acrylamide gradient and 
0.1% SDS (29). After electrophoresis, the slabs were stained, destained, and 
dried down onto paper for autoradiography  with Fuji x-ray t'tim (Fuji Photo 
Film Co. Ltd., Japan). Dried gels were exposed to film for 1-3 d. 
Two-dimensional  PAGE  was carried  out as described  by O'Farrell  (43), 
using isoclectrie focusing in the first dimension and SDS PAGE (10% polyac- 
rylamide) in the second dimension. The samples prepared for isoelectric focus- 
ing contained  1.4% LKB ampholytes, pH 5-7, plus 0.6% LKB ampholytes, pH 
3-10, 6 M urea, and 2% Nonidet P-40. The approximate pH range of the two- 
dimensional gels shown throughout the present paper was 4.5 (left) to 6 (right). 
Autoradiograms were scanned using a Joyce-Loehl double-beam microden- 
sitometer  and  the  incorporation  of 3zPl into  a  specific protein  band  was 
quantitated  by  measuring  the  peak  area  (Hewlen-Packard  digitizer) above 
background in densltomctry tracing as previously described (61). 
Peptide Mapping by Limited Proteolysis 
Peptide  mapping of the  80k  phosphoprotein  was carried  out according  to 
Cleveland et al. (6). The 80k band visualized by autoradiography was excised 
from several lanes of an SDS gel. Individual gel bands containing  the same 
amount of counts were rehydrated for 2 h in a solution containing  125 mM 
Tris-HCl, pH 6.8, 0.1% SDS, 1 mM EDTA, and placed into separate wells of 
a discontinuous  SDS PAGE (15% acrylamide). The gel bands were overlayed 
with 100 ~1 of  the same buffer containing  15% (wt/vol) glycerol, a trace amount 
of bromophenol blue,  and  different  amounts of Staphylococcus  aureus V8 
protease as indicated. Electrophoresis was carried out at 60 V. 
IzSI-EGF Binding 
12~I-EGF was prepared by the soluble lactoperoxidase procedure as previously 
described (57, 58). Cultures in 33-ram dishes were washed twice with DME at 
37"C and incubated  in  1 ml of binding  medium (1:1 mixture  of DME and 
Waymouth's medium containing 0.1%  crystalline  bovine serum albumin 
[BSA]- and 50 mM N,N bis [2-hydroxyethyl]-2-aminoethane sulphonic acid, 
pH 7.0, at 37"C, or phosphate-buffered saline [PBS] containing 0.1% crystalline 
BSA and 25 mM Hepes, pH 7.0, at 4'C). After the specified incubation period, 
the monolayer was washed rapidly three times with cold (4"C) PBS (pH 7.2) 
containing  0.1% BSA, extracted with 0.1  N NaOH containing  2% Na~ CO3 
and  1%  SDS, and cell-associated radioactivity  was determined  in a gamma 
counter. Nonspecific binding, determined as ceil-associated radioactivity in the 
presence of a  250-fold excess of unlabeled  EGF (or 250  ng/ml of EGF at 
concentrations  of t2~I-EGF below  1 ng/ml)  varied  linearly  with  ~2SI-EGF 
concentrations  and was -5% of the total binding at 50 ng/ml of t2~I-EGF and 
-2% at 0.5  ng/ml in cultures whether or not pretreated  with bombesin.  All 
values shown  are the mean of  duplicate determinations. Cell numbers  of  parallel 
cultures were measured by trypsinization and a Coulter counter. 
Materials 
In all experiments bombesin, PBh, and BSA (essentially fatty acid and globlin 
free) were from Sigma Chemical Co. (St Louis, MO). Neuromedin  B and the 
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Inc.  (Belmont, CA); GRP, (D-Arg  ~, o-Pro  2, D-Trp  7'9, Leu  tt) substance P (SP) 
and bombesin (8-14) were obtained from Bachem (Saffron  Walden, Essex, 
U.K.). EGF (receptor grade) was obtained from Collaborative Research Inc. 
(Lexington, MA). The fetal bovine serum was purchased from Gibco Europe 
(U.K.), and Staphylococcus aureus V8 protease was from Miles Laboratories, 
Ltd. (Stoke Poges, U.K.). 32po4 carrier-free  and Na t25I were obtained from the 
Radiochemical Centre (Amersham, U.K.) and the calcium ionophore A23187 
was obtained from Calbiochem-Behring  Corp., La Jolla, CA. All other materials 
were reagent grade. 
Results 
Bombesin Stimulates Phosphorylation of  80k 
The addition of bombesin to quiescent cultures of Swiss 3T3 
cells prelabeled with 32pi markedly increased the phosphoryl- 
ation of 80k (Fig.  1A). The time course for the stimulation of 
80k phosphorylation induced by bombesin is shown in Fig. 
1  B.  After addition  of the  peptide,  an  enhancement  in  80k 
phosphorylation was detected as early as  10 s, 32Pi incorpo- 
ration increased rapidly up to 1 min, and thereafter increased 
more slowly reaching a maximum at  10 min. A similar time 
course is obtained in response to addition of either PBt2  or 
serum  (49,  61)  while,  in  contrast,  PDGF  stimulates  80k 
phosphorylation after  a  lag of 1-2  min  (49).  The effect of 
bombesin on 80k phosphorylation is also concentration de- 
pendent  (Fig.  1 C); the  maximal  effect was obtained  at  1.5 
nM bombesin. 
Analysis by two-dimensional PAGE of  extracts of  quiescent 
3T3 cells labeled with 3~pi showed that the 80k phosphoryla- 
tion generated by bombesin migrates as an acidic protein with 
an isoelectric point (pI) of-5 (Fig. 2). A marked enhancement 
of 80k  phosphorylation could be  observed  1 min  after  the 
addition of bombesin; no further increase in phosphorylation 
of 80k was observed after  10 min (Fig.  2).  In other experi- 
ments,  a  1.5-fold increase  in  80k  phosphorylation was de- 
tected  by two-dimensional  PAGE analysis as early as  10  s 
after addition  of bombesin.  Quantitation  of the increase  in 
80k phosphorylation relative  to another prominent  spot of 
~55 kD (labeled A in Fig. 2), whose phosphorylation appears 
to increase more slowly after addition of bombesin, indicated 
relative increases in  the phosphorylation of 80k of 1.9  and 
1.6  after  1  and  10  min,  respectively.  However,  when  the 
enhancement  of 80k  phosphorylation  was  compared  with 
another less prominent spot of -52 kD (labeled B), relative 
increases of 3.7 and 2.8 in 80k phosphorylation were obtained 
after  1 and  10  min,  respectively.  Most  of the  radioactivity 
corresponding to 80k was eliminated  by alkaline  treatment 
(12), suggesting that the phosphorylation of 80k in response 
to  bombesin  occurs at  serine  rather  than  tyrosine  residues 
(results not shown). This is in agreement with results obtained 
for the  80k  phosphorylation  generated  in  response  to  the 
addition of PBt2 or serum (49, 61). 
Relationship between the 80k Phosphoproteins 
Generated in Response to Bombesin and PBt2 
The fact that the 80k phosphoproteins generated in response 
to the addition of  either serum, PBt:, or bombesin co-migrated 
in one-dimensional PAGE (Fig.  1A) suggested that bombesin 
stimulated the phosphorylation of an identical 80k protein to 
serum and PBt:. This possibility was substantiated by phos- 
phopeptide  mapping  using Staphylococcus aureus V8  pro- 
tease.  Peptide  mapping  of the  80k  phosphoprotein  bands 
generated  by bombesin  and  PBt: excised  from  one-dimen- 
sional PAGE showed the presence of similar phosphopeptide 
fragments  (results  not shown).  These  results suggested that 
the same 80k protein is generated in response to bombesin or 
PBt2.  To  test  this  conclusion  further,  extracts  of cultures 
exposed to bombesin or PBt: for 5 min were subjected to two- 
dimensional  electrophoresis.  As  shown  in  Fig.  3,  the  80k 
phosphoproteins produced after treatment with either bom- 
besin or PBt2 co-migrate with identical pI's. 
Prolonged exposure of cells to phorbol esters leads to both 
Figure 1. (A) The stimulation  of 80k phosphorylation  by bombesin  in quiescent Swiss 3T3 cells. Cultures were washed and labeled with 32pi 
for 4 h. After this time, cultures were challenged with bombesin at 6.2 nM (lane D), an equivalent volume of solvent (lane A), dialyzed fetal 
bovine serum at a concentration  of 10% (lane B), or PBh at 200 nM (lane C). Incubations  were terminated  after 5 min. The arrow indicates 
the position  of 80k. On the left, molecular weight standards  (x  10-3). (B) Time course of stimulation  of 80k phosphorylation  by bombesin. 
The cultures were washed and labeled with 3zp~ for 4 h. Bombesin at a concentration of 6.2 nM was added and the incubation  terminated  at 
various times. (C) Dose-response  curve for the stimulation  of 80k phosphorylation  by bombesin. The cultures were washed and labeled with 
32pi for 4  h, and then  challenged  with  either  various  concentrations  of bombesin  or an equivalent  volume of solvent.  Incubations  were 
terminated  after 5 min. Samples were analyzed for 32Pi incorporation  into 80k as described in Materials and Methods. 
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tors in intact cells (8-10, 54) and the disappearance of protein 
kinase C  activity in cell-free preparations (48), and it blocks 
the stimulation of 80k  phosphorylation in response to PBt2 
(61)  or the  synthetic diacylglycerol 1-oleoyl-2-acetylglycerol 
(OAG)  (59).  If the  enhancement  in  80k  phosphorylation 
caused by bombesin reflects the activation of protein kinase 
C,  prolonged pretreatment with PBt2  should also block the 
stimulation of 80k phosphorylation produced in response to 
bombesin. To test this possibility, cultures of Swiss 3T3 cells 
were treated with PBt2 at a saturating concentration (800 nM). 
After  40  h,  control  and  pretreated  cultures  were  washed 
extensively to  remove  residual  PBt2  (17)  and  then  labeled 
with  32pi. Prolonged  pretreatment  with  PBt2  completely 
blocked the stimulation of 80k phosphorylation caused by a 
subsequent challenge with bombesin as shown by both one- 
dimensional (Table I) and two-dimensional (Fig. 4)  PAGE. 
In Table I, the effect of pretreatment on the enhancement of 
80k phosphorylation by PBt2 is shown for comparison. 
The effect of prolonged exposure of 3T3  cells to PBt2 on 
the stimulation of 80k  phosphorylation by bombesin could 
also be due to a low rate of  turnover of  the 80k phosphoprotein 
generated by PBt2 during the early stages of the pretreatment. 
To test this possibility, cultures of 3T3 cells were pretreated 
Figure 2. Resolution of the 80k phosphoprotein by two-dimensional PAGE of extracts from bombesin-stimulated  3T3 cells. Quiescent cultures 
of Swiss 3T3 cells were labeled with 32P  i for 4 h. Bombesin was then added at a concentration of 6.2 nM and the incubations terminated after 
the indicated times. In the first dimension, phosphoproteins were separated by isoelectrofocusing from the right (basic) to the left (acidic). The 
arrows indicate the position of 80k.  The letters A and B indicate the positions of two reference  proteins whose phosphorylation state was 
compared with that of 80k (see text for details). On the left, molecular weight standards (x 10-3). 
Figure 3. Resolution of the 80k phosphoprotein by two-dimensional PAGE of extracts from control and either PBt2 or bombesin-stimulated 
3T3 cells. Quiescent cultures of Swiss 3T3 cells were labeled with 32Pi for 4 h. They were then treated for 5 min with 200 nM PBt2, 6.2 nM 
bombesin, or with an equivalent volume of solvent (control). Quantitation of the 80k phosphoprotein generated by bombesin relative to spots 
A and B showed increases of 1.6 and 4.4, respectively. The corresponding values for PBt2 were 2.5 and 2.7, respectively. Other experimental 
details were as described in the legend to Fig. 2. The arrow indicates the position of 80k. On the left, molecular weight standards (x t0-3). 
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Under these  conditions,  there  is  neither  a  reduction  in  the 
number of phorbol ester-binding sites (10),  nor a  decreasee 
in the activity of protein  kinase C  in cell-free extracts (48). 
Pretreatment with PBt2 for 1 h  failed to block the increase in 
80k phosphorylation induced by a subsequent challenge with 
either bombesin or PBt2. 
Bombesin Inhibition of 12SI-EGF Binding: Dependence 
on Time,  Temperature, and Ligand Concentration 
Treatment with bombesin at 6.2 nM caused a marked reduc- 
tion in the binding of ~2SI-EGF to Swiss 3T3 cells (Fig. 5A). 
As judged by the selective removal of cell surface-bound I2~I- 
EGF by treatment with acetic acid (24), 88% of the total 125I- 
EGF bound was on the cell surface after  I min whereas only 
37%  of the  total  radioactivity associated  with  the  cells  re- 
mained surface bound after  12 rain of incubation (Fig. 5B). 
The  salient  feature  of the  results  shown  in  Fig.  5 B  is  that 
bombesin decreased the surface-bound lzSI-EGF as early as  l 
Table L Pretreatment with PBt2 Blocks the Stimulation of 
80k Phosphorylation by Bombesin and PBt2 
80k phosphorylation  (% of control) 
Additions  Control  Pretreated 
--  100  76.5 
PBt2  335  101 
Bombesin  295  100 
Quiescent  cultures  of Swiss 3T3  ceils were incubated  either  in  the  absence 
(control) or presence (pretreated) of 800 nM PBt2 for 40 h. The cultures were 
washed, labeled with 32pi for 4 h, and exposed to either 200 nM PBt2, 6.2 nM 
bombesin,  or an equivalent  volume  of solvent. The reaction  was terminated 
after 5 min. Samples were analyzed for 32p~ incorporation  into 80k as described 
in Materials and Methods. Values represent the mean of results obtained from 
two separate experiments.  Other experimental  details were performed  as de- 
scribed in Materials and Methods. 
min of incubation.  This strongly suggests that bombesin in- 
hibits the binding of 125I-EGF to surface receptors rather than 
a subsequent step in the interaction of EGF with 3T3 cells. 
Since  the  EGF-receptor  complexes  are  internalized  and 
degraded at 37"C but not at 4"C (44), we examined the effect 
of temperature  on  the  ability  of bombesin  to  inhibit  the 
binding of 125I-EGF to 3T3 cells. At 37"C, bombesin inhibited 
~25I-EGF binding in a concentration-dependent fashion; half- 
maximal  inhibition  was elicited  at  a  concentration  of 0.15 
nM and maximal inhibition (85%) was achieved at 6.2  nM 
(Fig.  6).  The inhibition  of L25I-EGF binding was strikingly 
reduced  when  the  temperature  of the  incubation  was  de- 
creased from 37"C to 4"C (Fig. 6); at 4"C, bombesin failed to 
inhibit  IzSI-EGF binding  to  3T3  cells.  However,  when  the 
cultures were preincubated with bombesin at 37"C for 1 h (in 
the  absence  of ~25I-EGF) and  ~25I-EGF binding  was subse- 
quently measured at 4"C, a concentration-dependent inhibi- 
tion of binding  was observed (inset,  Fig.  6).  This  indicates 
that the decrease in  ~zSI-EGF binding induced by bombesin 
can be elicited in the absence of  EGF and that once established 
at  37°C the decrease  is  not readily reversed at  4"C.  In this 
manner, the effect ofbombesin on the interaction of ~25I-EGF 
with cellular receptors can be ascertained in the absence of 
ligand internalization and degradation.  Using this approach, 
we determined the effect of bombesin on ~25I-EGF binding as 
a  function of ligand concentration. The inhibition  by bom- 
besin was competitive, with no change in maximal binding 
but with a considerable increase in the concentration of ~25I- 
EGF required  for half-maximal binding (Fig.  7).  Scatchard 
analysis of these data (shown in the inset) revealed that  ~25I- 
EGF binds to a population of receptors of mixed affinity with 
apparent dissociation constants (Kd) of  0.1 and 1.7 nM. Treat- 
ment with bombesin did not affect the total number of EGF 
receptors present on the cells (85,000 sites/cell) but markedly 
decreased the affinity of the receptor population to an almost 
uniform Kd value of 3 nM. 
Figure 4.  (Left) Resolution of the  80k  phosphoprotein by two-dimensional PAGE of extracts from control and PBt2-pretreated  3T3  cells. 
Subsequent addition  of PBt2 or bombesin to stimulate 80k phosphorylation.  Quiescent cultures of Swiss 3T3 cells were incubated either in the 
absence (left and center) or presence (right) of 800 nM PBt2 for 40 h. The cultures were washed, labeled with 32pi for 4 h and exposed to either 
6.2 nM bombesin (center and right), or an equivalent  volume of solvent (left). The reaction was terminated  after 5 rain. Control pretreated 
cultures subsequently exposed to an equivalent volume of solvent showed no differences in the level of 80k phosphorylation  from the control 
panel.  Quantitation of the  80k phosphoprotein  generated  by bombesin  relative to spots A and B showed that PBt2 pretreatment  reduced 
bombesin stimulation  of 80k phosphorylation  to the control value. Other experimental details were as described in the legend to Fig. 2. In both 
control and pretreated  cultures, bombesin  markedly stimulated  the phosphorylation  of a spot migrating with a molecular  mass of -93 kD. 
However, this spot was not observed in the other experiments shown in this paper. The arrow indicates the position of 80k. 
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Figure 5. Time course of '25I-EGF  binding 
to Swiss  3T3 cells in the presence or absence 
of bombesin.  (A)  Quiescent  cultures  of 
45  Swiss 3T3 cells were incubated at 37"C with 
1 ml of binding  medium containing  0.5 ng/ 
ml  (150,000 cpm/ng),  K25I-EGF without 
(squares) or with (circles)  6.2 nM bombesin. 
Cell-associated  radioactivity  was  deter- 
mined at the indicated times as described 
30  in Materials and Methods. (B) Time course 
of surface-bound (triangles) and internal- 
ized  (diamonds)  J2~I-EGF in  quiescent 
Swiss 3T3 cells. The cultures grown in 33- 
mm dishes were incubated at 37"C with  I 
ml of binding medium containing 1 ng/ml 
IS  (150,000  cpm/ng) J25I-EGF in the absence 
(open  symbols) or presence (closed sym- 
bols) of 6.2 nM bombesin. At the indicated 
times, surface-bound  J25I-EGF was deter- 
mined by extracting with 0.5 ml of a solu- 
tion containing 0.2  M  acetic acid/0.5  M 
NaC1 at 4"C for 6 min. The internalized 
radioactivity was measured as described for 
total cell-associated radioactivity in Mate- 
rials and Methods. 
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Figure 6. Effect of temperature  on the in- 
hibition of t25I-EGF binding to Swiss 3T3 
cells  by  bombesin.  Confluent  quiescent 
Swiss 3T3  cells were washed twice with 
binding medium at  37"C and  incubated 
(after equilibration for 5 rain at the required 
temperature) with 1 ml of binding  medium, 
containing  0.5 ng/ml (90,000 cpm/ng) 125I- 
EGF for 1 h at the following temperatures: 
4"C (open circles); 8"C (solid squares); 24"C 
(solid triangles) and 37"C (solid circles). The 
total cell-associated  radioactivity was deter- 
mined as described in Materials and Meth- 
ods. The results were expressed as a per- 
centage of the mean control values at the 
different  temperatures.  The  100% values 
(mean __+ SEM; n = 4) in each case were as 
follows: 208 --- 2 pg/10  6 cells at 37"C; 177 _  3.5 pg/106 cells at 24"C; 140 + 5.0 pg/106 cells at 8"C; and 96 __+ 1.0 pg/106 cells at 4"C. (Inset) 
Confluent quiescent cultures of Swiss 3T3 cells were transferred to 1 ml of DME with the concentrations of bombesin indicated and incubated 
at 37"C for 1 h. The cultures were washed five times with DME containing  0.1% BSA at 37"C. All cultures were then chilled in 1 ml of binding 
medium on ice for 5 min, and incubated for 2 h at 4"C in 1 ml of binding medium containing 0.5 ng/ml (110,000 cpm/ng) ~2SI-EGF.  Cell- 
associated radioactivity was then determined as described in Materials and Methods. The values shown represent the percentage of the mean 
control value, 74 _+ 2 pg/106 cells (mean __+ SEM; n -- 6). 
The Effect of  Bombesin on 80k Phosphorylation and 
EGF Receptor Affinity is Mediated by the 
Bombesin Receptor 
To determine whether the stimulation  of 80k phosphorylation 
and the transmodulation of the EGF receptor by peptides of 
the bombesin family were mediated by specific high-affinity 
receptors for these peptides, we tested the ability of a range of 
bombesin agonists to induce these responses. GRP is a  27- 
amino acid peptide identified in mammalian gut (36,  70), 
brain (40,  70),  and lung (21,  71).  Neuromedin B  is one of 
another class of bombesin-like peptides isolated from brain 
and spinal cord (38, 39). As shown in Table II, these peptides 
exhibit striking sequence homology with the highly conserved 
COOH-terminal heptapeptide  of bombesin (the  8-14  frag- 
ment ofbombesin). GRP, neuromedin-B, and the 8-14 frag- 
ment of bombesin, designated bombesin(8-14), all markedly 
increased 80k phosphorylation  (Fig. 8) and inhibited t25I-EGF 
binding  (see Fig. 10, upper panel) in a concentration-depend- 
ent fashion. In contrast, the amino-terminal  fragment of  GRP, 
designated GRP(I-16), did not elicit these responses even at 
concentrations as high as 5 /zg/ml (see  Fig.  10 upper panel; 
and results not shown). 
The substance P  (SP) analogue (D-Arg  ~,  D-Pro  2,  D,-Wl'p  7'9, 
Leu  1~) SP (33), recently described as a novel bombesin antag- 
onist (27), markedly inhibits both (J25I-Tyr') GRP binding, 
and bombesin-  and GRP-induced mitogenesis in a concentra- 
tion-dependent  manner (73). The antagonist at 100 ~M com- 
pletely abolished the stimulation of 80k phosphorylation pro- 
moted by bombesin and GRP (Fig. 9). Furthermore, (D-Arg I, 
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Figure 7. Effect of bombesin on the binding of 125I- 
EGF to Swiss  3T3  cells as a  function of ~25I-EGF 
concentration.  Confluent,  quiescent  cultures  of 
Swiss  3T3 cells were transferred to  1 ml of DME 
with no addition (squares) or with 6.2 nM (circles) 
bombesin at 37"C for 1 h. Cultures were washed five 
times with DME containing 0.1% BSA at 37"C. All 
cultures were then chilled in  1 mi of binding me- 
dium on ice for 5 min, and incubated for 2 h at 4"C 
in  1 mi of binding medium containing ~25I-EGF at 
the concentrations shown. Detailed analysis of the 
time course of the binding of various levels of ~25I- 
EGF to Swiss 3T3 cells demonstrated that even at 
the lowest levels of ~2~I-EGF  used, equilibrium bind- 
ing  was  obtained  after  this  time.  Cell-associated 
radioactivity was then determined  as described in 
Materials and Methods. The values shown represent 
specific binding,  measured  for  each  condition as 
that displaced by the presence of 250-fold excess (or 
250 ng/ml at ~25I-EGF levels below 1 ng/ml) unla- 
beled EGF. The inset shows Scatchard analysis of 
the data (B/F vs. B); B, bound t2SI-EGF, is expressed 
as pmol/106 cells,  whereas F, the concentration of 
~25I-EGF in the binding solution, is in pmol/ml. 
Table I1. Amino Acid Sequence of  Peptides of  the Bombesin Family 
GRP (1-27) 
Bombesin 






Ala Pro Val Ser Val Gly Gly Gly Thr Val Leu Ala Lys Met Tyr Pro Arg Gly Asn His Trp Ala Val Gly His Leu Met 
Glu Gin Arg Leu Gly Asn Gin Trp Ala Val Gly His Leu Met 
Met Tyr Pro Arg Gly Asn His Trp Ala Val Gly His Leu Met 
Glu Gin Trp Ala Val Gly His Phe Met 
Gin Asn His Trp Ala Val Gly His Leu Met 
Gly Asn Leu Trp Ala Thr Gly His Phe Met 
Trp Ala Val Gly His Leu Met 
Ala Pro Val Ser Val Gly Gly Gly Thr Val Leu Ala Lys Met Tyr Pro 
Figure 8.  Dose-response for the stimulation  of 80k phosphorylation  in quiescent Swiss  3T3  cells by the bombesin-related peptides GRP, 
neuromedin B (NMB), and bombesin(8-14)[B (8-14)]. Cultures were washed and labeled with 32p~ for 4 h. After this time, either peptide was 
added at the concentrations indicated, or cultures were challenged with an equivalent volume of solvent (C). Incubations were terminated after 
5 min. The arrow indicates the position of 80k. On the far left of each series of gels, molecular weight standards (×  10-3). 
Zachary et al. Bornbesin  Activation of  Protein Kinase  C  22 i 7 o-Pro 2, D-Tv107"9, Leu H) SP had no effect on t25I-EGF binding 
in the absence of bombesin, but caused an eightfold increase 
in  the  concentration  of bombesin  required to  induce  half- 
maximal inhibition of ~25I-EGF binding (Fig. 10, lower panel). 
The effect of the antagonist on both the stimulation of 80k 
phosphorylation and  the  inhibition of ~25I-EGF binding by 
Figure 9.  The  inhibition of bombesin- and  GRP-stimulated 80k 
phosphorylation in quiescent Swiss 3T3 cells by the bombesin antag- 
onist (D-Arg  ~, D-Pro  2, D-Trp  7"9, teu I  i) SP. Cultures were washed and 
labeled with 32p  i for 4 h. After this time, cultures were incubated for 
5 min either in the absence (-) or in the presence (+) of (D-Arg  1, D- 
Pro  2, D_TrpT.9, teu 11) SP at a concentration of 100 vM. Cultures were 
then  challenged  with  either PBt2 at  a  concentration  of 200  nM, 
bombesin at 2 nM, GRP at 2 nM, or with an equivalent volume of 
solvent. Quantitation of  the increase in 80k phosphorylation  corrected 
to account for variations in the loading of the lanes showed  2.9-, 
2.2-, and 2.2-fold stimulation, respectively, for PBh, bombesin, and 
GRP in the absence of the antagonist. The corresponding values for 
PBt2, bombesin, and GRP in the presence of the antagonist were 3.7, 
1.0, and 0.9 respectively. The arrow indicates the position of 80k. On 
the left, molecular weight standards (x 10-3). 
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bombesin was selective; at  100  uM,  the  antagonist had  no 
effect upon either the increase in 80k phosphorylation caused 
by PBt2 (Fig. 9) or the inhibition of 125I-EGF binding by either 
PDGF or PBt2 (Fig. 10, lower panel). 
Role of  lncreased Cytosolic Ca  2+ and Protein Kinase 
C in Mediating Transmodulation of the EGF Receptor 
It has been suggested that a variety of secretagogues, including 
bombesin, inhibit  125I-EGF association to pancreatic acinar 
cells by increasing cytosolic Ca  2÷ in the cells (28, 31, 46). The 
following paper (37)  reports that  bombesin  and bombesin- 
related peptides induce Ca  2÷ mobilization from intracellular 
stores and increase cytosolic Ca  2÷ concentration in 3T3 cells 
(37). To evaluate the role of Ca  2÷ in mediating the inhibition 
of ~2~I-EGF binding by these peptides, we tested the effect of 
the Ca  2÷ ionophore A23187 on  125I-EGF binding to cultures 
of quiescent Swiss 3T3 cells. At 37"C, the drug caused inhi- 
bition of cell-associated 125I-EGF in a  concentration-depend- 
ent manner;  however, even at  1 /~M,  A23187  produced an 
inhibition  of only  34%  (Fig.  l 1).  The  maximal  effect  of 
bombesin at 37"C was 85%  and it is shown for comparison. 
In  addition,  treatment  of the  cells  at  37"C  with  A23187 
followed by binding at 4"C markedly decreased the ability of 
the drug to inhibit 12SI-EGF binding (Fig.  l 1). In contrast to 
bombesin, which affected surface-bound 12SI-EGF as early as 
1 min (Fig. 5 B), A23187 reduced internalized ~25I-EGF only 
after 15-30 min of incubation (Table III). The striking differ- 
ences between bombesin and A23187  in their ability to de- 
crease ~25I-EGF binding to 3T3  cells indicates that the inhi- 
bition of 125I-EGF  binding to  3T3  cells by peptides of the 
bombesin family is not mediated by an increase in the intra- 
cellular concentration of Ca  2÷ in these cells. 
As shown in Fig. 4 and Table I, prolonged pretreatment of 
quiescent Swiss 3T3 cells with PBt2,  which reduces the num- 
Figure 10. Inhibition of 1251-EGF binding to Swiss 
3T3  cells  as  a  function  of the  concentration  of 
bombesin-related peptides. (Upper panel) The cul- 
tures were washed twice with DME and incubated 
for 1 h at 37"C in l ml of binding medium contain- 
ing 0.5  ng/ml  (90,000  cpm/ng)  I:SI-EGF in  the 
absence  or presence  of the bombesin-related pep- 
tides GRP 1-27, neuromedin B (NB), bombesin(8- 
14) (BOM 8-14), and GRP  1-16 at the concentra- 
tions indicated. The cultures were then washed and 
cell-associated radioactivity was determined as de- 
scribed in Materials and Methods. Each point rep- 
resents the mean value obtained (n --- 4) expressed 
as a percentage of the mean control value of 159 ± 
5.5 pg/106 cells (mean +_. SEM; n = 8). (Lower  panel) 
Effect  of (D-Arg l,  D-Pro  2,  n-Trp  7"9, Leu  H) SP  on 
inhibition of ~2~I-EGF  binding by bombesin, PDGF, 
and PBt2. Confluent quiescent Swiss 3T3  cultures 
were washed twice with DME and incubated in  1 
ml  of  binding  medium  containing  0.5  ng/ml 
(125,000 cpm/ng) I2~I-EGF  at 37"C for 1 h, at the 
concentrations of bombesin, PDGF, and PBt2 indi- 
cated either in the absence (solid circles and solid 
bars) or the presence (open circles and open bars) of 
(D-Arg 1, D-Pro  2, D-Trp  7'9, teu  II  ) SP at 100 vM. The 
cell-associated radioactivity was determined as de- 
scribed in Materials and Methods and expressed as 
a percentage  of the mean controls which were  184 
_  2 pg/106 cells (mean ± SEM; n = 4) in all cases. 
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Figure 11. Effect of A23187 on ~25I-EGF  binding to 
Swiss  3T3  cells.  Confluent,  quiescent  cultures  of 
Swiss  3T3  cells were washed  twice with  DME at 
37"C. Some cultures were incubated for t h at 37"C 
in binding medium containing 0.5 ng/ml (127,000 
cpm/ng)  t25I-EGF and  either bombesin (solid cir- 
cles) or A23187 (solid squares) at the concentrations 
shown. Cell-associated radioactivity was determined 
as  described  in  Materials  and  Methods  and  ex- 
pressed as a percentage of the control value 186 + 
3 pg/l& ceils (mean ±  SEM; n -- 4). Other cultures 
(open  squares)  were  chilled on  ice  for  5  min  in 
binding medium, then incubated for 2 h at 4"C in 
binding  medium  containing  0.5  ng/ml  (127,000 
cpm/ng) t2~I-EGF, in the presence of  A23187 at the 
concentrations shown. The cell-associated radioac- 
tivity was then determined and expressed as a per- 
centage of mean control value 100 ±  2 pg/106 cells 
(mean ±  SEM; n -- 4). Finally, cultures were incu- 
bated  at  37°C for  1 h  with  1 ml  of DME in  the 
presence of A23187 (semi-open squares) at concen- 
trations indicated, then washed five times with DME containing 0.1%  BSA at 37"C and chilled in binding medium on ice for 5 min. The 
cultures were then incubated  for 2  h  at 4"C in  1 ml of binding medium containing  ~25I-EGF (as  above). Cell-associated radioactivity was 
determined as before and the results expressed as a percentage of the control 99 _+ 2 pg/106  cells (mean _+ SEM; n =  6). 
Table IlL Effect of  the Ca  2+ Ionophore A23187 on Surface- 
bound and Internalized ~2SI-EGF 
'251-EGF (pg/106 cells)  v 
"O  Addition  Time  Surface-bound  Internalized  = 
O 
--  5  48  _  1.0  48 _  0.5  m 
A23187  5  42.5 __  1.8  41  +  1.0  ,, 
--  15  48 + 0.9  90 +  2.0 
U.I 
A23187  15  48 __ 2.0  70 ±  2.0  t 
--  30  49 __. 0.5  180 _  1.2 
A23187  30  50 -- 2.0  112 -- 5.0 
Quiescent cultures of Swiss 3T3 cells were incubated at 37"C  in 1 ml of binding 
medium containing 1 ng/ml (125,000 cpm/ng) t2SI-EGF  either in the absence 
or in the presence of 1 vM A23187. At the indicated times the surface-bound 
J251-EGF  was determined by extracting with 0.5 ml of  a solution containing 0.2 
M acetic acid/0.5 M NaCI at 4"C for 6 min. The internalized radioactivity was 
measured as described in Materials and Methods. The figures represent mean 
-+ SEM; n = 4. 
ber of phorbol ester-binding sites (8-10,  54) and the activity 
of protein  kinase  C  measured  in  cell-free preparations  (48, 
60), prevents the activation of protein kinase C  by bombesin. 
If the inhibition of ~25I-EGF binding by bombesin is mediated 
by  activation  of protein  kinase  C,  pretreatment  with  PBt2 
should  reduce  the  inhibition  of binding  caused  by  a  subse- 
quent exposure to bombesin.  As shown in Fig.  12, treatment 
of 3T3 cells with PBt2 for 40 h  followed by extensive washing 
to remove residual PBt2 (17) prevented the inhibition of t25I- 
EGF binding by a subsequent addition of either bombesin or 
PBt2 to these pretreated cells. 
Discussion 
The  findings  presented  here  demonstrate  that  addition  of 
bombesin to intact, quiescent Swiss 3T3 cells rapidly enhances 
the phosphorylation  of 80k.  The  effect is concentration  de- 
pendent and can be detected as early as 10 s after the addition 
of bombesin.  Recently, a  rapid  stimulation  in  the phospho- 
rylation  of 80k  by  phorbol  esters  (61)  or by OAG  (59)  has 
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Figure 12. Effect of prolonged pretreatment with PBt2 on the inhibi- 
tion of t2~I-EGF binding to Swiss 3T3 cells caused by a subsequent 
addition of bombesin or PBt2. Quiescent Swiss 3T3 cells were incu- 
bated for 40 h in a mixture of their own conditioned medium, fresh 
DME, and Waymouth medium in a ratio of 1:1.5:1.5,  either in the 
absence (solid circles, solid squares)  or the presence  (open  circles, 
open squares) of 400 nM PBt2. At this time, the cells were washed 
three times in DME containing 1 mg/ml BSA and incubated in this 
medium  for 20  min  at  37"C before two  final washes in the  same 
medium.  This procedure was shown previously to remove residual 
PBt2 (17).  The cultures were then incubated for 1 h at 37"C in  1 ml 
of DME containing bombesin (solid and open circles) or PBt2 (solid 
and open squares) at the concentrations shown. The cultures were 
then washed five times with DME containing 1 mg/ml BSA at 37"C. 
All cultures were then chilled in  1 ml of binding medium on ice for 
5  min, and incubated  for 2  h  at 4"C in  1 ml of binding medium 
containing  0.5  ng/ml  (110,000  cpm/ng)  ~2~I-EGF. Cell-associated 
radioactivity  was  then  determined  as  described  in  Materials  and 
Methods. The results expressed as the percentage of  the mean control 
value, 74 ±  2  pg/106  cells (mean ±  SEM; n  =  6) in the absence of 
PBt2 pretreatment and 76 ___ 3.5 pg/106 cells (mean _+ SEM; n  =  6) 
in PBt2-pretreated cultures. 
been  shown  to  reflect the activation  of protein  kinase  C  in 
intact cells (60).  The possibility that the same 80k phospho- 
protein is generated  in response to both bombesin  and  PBt2 
is supported  by analysis in one- and two-dimensional PAGE 
Zachary et at. Bombesin Activation of  Protein Kinase  C  2219 and  by peptide  mapping  after limited proteolysis with  V8 
protease. The conclusion that the enhancement in 80k phos- 
phorylation by peptides of the bombesin family also reflects 
the activation of protein kinase C is further substantiated by 
experiments in which 3T3 cells are exposed to PBh for 40 h 
before the  assay.  This  prolonged  pretreatment  leads  to  a 
striking reduction in the number of specific [aH]-PBt2 binding 
sites in intact cells (8-10, 54) in the protein kinase C activity 
measured in partially purified cell-free extracts (48, 60), and 
in the early and late responses of the cells to a  subsequent 
challenge with phorbol esters (8-10, 54,  59-61). The results 
presented here demonstrate that prolonged pretreatment of 
3T3 cells with PBt~ blocks the stimulation of 80k phospho- 
rylation elicited by bombesin. Taken together, these findings 
indicate  that  the  peptides  of the  bombesin  family rapidly 
activate protein kinase C  activity in intact Swiss 3T3 cells. 
Since the activation of protein kinase C acts as a  mitogenic 
signal  for Swiss 3T3 cells (60),  the stimulation of this phos- 
photransferase system may play a fundamental role in effect- 
ing the proliferative response elicited by bombesin and struc- 
turally related peptides. 
Our results also show that bombesin causes a  rapid and 
striking inhibition of ~25I-EGF binding to cultures of Swiss 
3T3 cells. The data strongly suggest that the inhibition of ~25I- 
EGF binding by bombesin occurs at the level of the interac- 
tion of ~25I-EGF with its receptor at the cell surface, rather 
than at some subsequent step such as ligand internalization 
and degradation. A decrease in the specific binding ofa ligand 
can be due to a decrease in the apparent number of available 
receptors (e.g., after down regulation) or to a change in the 
apparent affinity of the receptor population or to a  combi- 
nation  of these  mechanisms.  Bombesin  treatment did  not 
decrease the apparent maximum number of EGF receptors 
but caused a considerable decrease in the apparent affinity of 
the receptors from a mixed population with kD values of 0.1 
and 1.7 nM to receptors with a kD of ~3 nM. Thus, bombesin 
inhibition  of EGF  binding  in  Swiss  3T3  cells  has  many 
properties similar to that induced by other ligands  that elicit 
receptor transmodulation (54),  including phorbol esters (5, 
30, 63), synthetic diacylglycerol OAG (64), vasopressin (57), 
PDGF (3,  11), and FDGF (58). All these tumor- and growth- 
promoting agents decrease the apparent affinity of the EGF 
receptor population in a temperature-sensitive manner (trans- 
modulation) without any decrease in the EGF receptor num- 
ber due to down regulation. 
Peptides of the  bombesin  family bind  to  specific,  high- 
affinity sites in Swiss 3T3 cells that mediate their mitogenic 
effects in  these  cells  (73).  Our  results demonstrate a  close 
correspondence between the ability of peptides of the bom- 
besin family to stimulate 80k phosphorylation and both their 
relative mitogenic potency and ability to inhibit GRP binding 
(73). Further, the novel bombesin antagonist, (D-Arg  ~, D-Pro  2, 
D-Trp  7'9, Leu ~) SP (27) abolished the increase in 80k phos- 
phorylation induced by bombesin and GRP at a concentra- 
tion (100 gM) similar to that required to block both mito- 
genesis and receptor binding (73). Likewise, the relative abil- 
ities of bombesin-related peptides to inhibit ~2SI-EGF  binding 
closely correspond to  their capacity to displace (~25I-Tyr~) 
GRP from its high-affinity binding site (73). Further, (D-Arg  ~, 
D-Pro  2,  D-Trp  7"9, Leu  ~) SP (27,  73) competitively inhibited 
the effect of bombesin on ~25I-EGF  binding. These structure- 
activity relationships strongly suggest that both the activation 
of protein kinase C and the modulation of ~25I-EGF binding 
to its receptor by peptides of the bombesin family are medi- 
ated by the specific  high-affinity receptors which have been 
characterized in Swiss 3T3 cells (73). 
The nature of the intracellular signals generaged by bom- 
besin and other mitogenic ligands which lead to the activation 
of protein  kinase  C  remains  unclear,  though  it  has  been 
suggested that biologically active peptides or hormones that 
activate protein kinase C do so through phospholipid break- 
down leading to diacylglycerol formation and to an increase 
in cytosolic Ca  2+ (2, 42). Indeed, in the following paper (37) 
we  show that peptides of the bombesin family stimulate a 
rapid  (15  s)  mobilization of Ca  2÷  from intracellular stores 
(37). Since it has been proposed that an increase in the cellular 
concentration of Ca  ~÷ decreases the association of ~zSI-EGF 
to  pancreatic acinar  cells  (28,  31,  46)  and  to  the  human 
epidermoid carcinoma cell line KB (20), it was important to 
evaluate the  role of this  putative second messenger in  the 
action of bombesin on the binding of ~25I-EGF to 3T3 cells. 
We found that the Ca  2+ ionophore A23187 does not mimic 
the effect of bombesin in terms of either maximal inhibition 
of binding  or  dependence on  temperature.  Further,  when 
A23187 was added at 50 nM, a concentration that caused an 
increase in cytosolic Ca  2+  comparable to that induced by a 
saturating dose ofbombesin (37), the ionophore had no effect 
on cell-associated  ~25I-EGF. Finally, while bombesin strikingly 
decreased  surface-bound  ~2SI-EGF as  early  as  1  min,  the 
ionophore only reduced the amount of internalized ~25I-EGF 
at later times of incubation. We conclude that an increase in 
cytosolic concentration of Ca  2÷ does not mediate the inhibi- 
tory effect of bombesin on  125I-EGF binding-in  Swiss  3T3 
cells. 
A salient feature of the results presented here is that pro- 
longed incubation with PBh, which prevents the activation of 
protein kinase C by bombesin, also abolished the inhibition 
of ~25I-EGF binding by a subsequent addition of either PBt2 
or bombesin. Scatchard analysis of ~25I-EGF binding at 4"C 
after the prolonged PBh treatment demonstrated that  this 
procedure did not affect the apparent number or affinity of 
the EGF receptor. In addition, EGF was mitogenic in PBt2- 
treated cells (10). These important controls indicate that the 
EGF receptor is present and functional in PBt2-desensitized 
cells. The loss of response to bombesin in cells with greatly 
reduced numbers ofphorbol ester receptors  and protein kinase 
C activity strongly implicates this phosphotransferase system 
in mediating transmodulation of the EGF receptor by bom- 
besin  in  intact  3T3  cells.  This enzyme phosphorylates the 
EGF receptor at a specific site (7,  15, 25, 26) located in the 
intracellular portion of the receptor, nine residues from the 
proposed  hydrophobic  transmembrane  domain  (25).  Al- 
though the precise effect of this phosphorylation on the affin- 
ity of the EGF receptor remains unclear, it is plausible that 
protein kinase C may play a direct role in mediating trans- 
modulation of EGF receptors in intact cells. 
The results presented in this and the following paper (37) 
demonstrat~ that bombesin and structurally related peptides 
elicit a  complex set of early events in quiescent Swiss 3T3 
cells (summarized in Fig.  13). These peptides, which exhibit 
a  highly conserved carboxyl-terminal heptapeptide, bind to 
specific,  high-affinity receptors (73).  After binding,  these li- 
gands rapidly stimulate (a) the phosphorylation of 80k, which 
reflects the activation of protein kinase C in intact 3T3 cells; 
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Figure 13. Early events elicited by bombesin and structurally related 
peptides in quiescent Swiss 3T3 cells. The cause-effect relationships 
indicated  by  the  arrows  are  discussed  in  detail  here  and  in  the 
following paper (37). 
(b) mobilization of Ca  2+  from an  intracellular store which 
leads to a transient increase in the concentration of cytosolic 
Ca  2+  and  Ca  2÷  effiux (37);  and  (c) the  activity of Na+/H  ÷ 
antiport which, in turn, activates Na+/K  + pump activity and 
increases  intracellular  pH  (37).  The  activation  of protein 
kinase C mediates, at least in part, the changes in monovalent 
ionic fluxes (37).  As shown in this paper, activation of this 
phosphotransferase  system  is  also  implicated  in  inducing 
transmodulation  of EGF receptor affinity. These early re- 
sponses are strikingly similar to those elicited by PDGF and 
FDGF, a PDGF-Iike growth factor (3, 11, 32, 49, 58, 61, 66). 
In contrast to many other factors which are mitogenic only 
when added in synergistic combinations (53,  55), bombesin, 
PDGF, and  FDGF stimulate  DNA synthesis in  Swiss  3T3 
cells in the absence of other mitogenic factors (32, 56, 66). It 
has  been  hypothesized that  initiation  of a  proliferative re- 
sponse  results  from the  synergistic interaction of multiple 
complementary signals  (discussed  in  53,  55).  The fact that 
bombesin, like PDGF and FDGF, triggers  a wide variety of 
signalling  processes (Fig.  13) is entirely consistent with this 
hypothesis.  Further  studies  comparing the  early biological 
responses elicited by these mitogens may provide important 
clues regarding the nature and role of the signals  and early 
events that precede fibroblast cell proliferation. 
Received  for  publication  9  August  1985,  and  in  revised  form  1 
February 1986. 
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